Bacrlax Injection 250mg (Acyclovir)

Adult dosage

When using tablets, capsules, syrup, or suspension: 1. Treatment of herpes simplex virus infection: As acyclovir, 200 mg 5 times a day every 4 hours for 5 days, and may extend treatment in cases of severe primary infection. 2. Prevention of herpes simplex infection in patients with normal immune function: 200 mg every 6 hours, 4 times a day or 400 mg every 12 hours, 2 times a day. 3.

Children's dosage

Children over 2 years: Follow the same dosage as adults. Children under 2 years: Administer half the adult dosage. For the treatment of chickenpox in children over 2 years: Administer 20 mg per kg body weight per dose (maximum 800 mg), 4 times a day for 5 days.

This medication should not be used in patients who are allergic to this medication or its components. In patients with poor kidney function, this medication should be used with caution, and monitoring is needed as central nervous system symptoms may occur. It should also be administered cautiously to patients with impaired liver function, as the risk of worsening liver function may increase. In infants and children, it should be used minimally and only when necessary, especially in neonates or premature infants where safety has not been established, caution is required. Elderly patients are likely to have reduced kidney function, which may increase the concentration of this medication, therefore, careful administration with adjusted dosage and intervals is necessary. Serious allergic reactions such as anaphylactic shock may rarely occur when this medication is used; if symptoms such as low blood pressure, difficulty breathing, or chest tightness occur, administration should be stopped immediately, and appropriate treatment should be sought. Skin reactions such as rash, fever, blisters, or urticaria may occur, so if these symptoms appear, administration should be discontinued. Rarely, hair loss, severe skin diseases, neurological symptoms (e.g., confusion, hallucinations, seizures), kidney issues, liver function abnormalities, gastrointestinal symptoms (gastritis, nausea, vomiting, etc.), blood abnormalities, and cardiovascular issues may occur, and if any abnormal symptoms arise, report to medical personnel immediately. It is most effective to administer this medication as early as possible after disease onset, particularly starting as soon as possible after symptoms of herpes zoster or chickenpox appear. During administration, it is important to maintain adequate hydration to prevent dehydration and reduce the risk of kidney toxicity. Interactions may occur when used with other medications, so inform medical personnel of any current medications you are taking. Women who are pregnant or may become pregnant should only use this medication if the benefits outweigh the risks to the fetus. This medication is also excreted in breast milk, so it is recommended to discontinue breastfeeding during treatment. In case of overdose, kidney damage may occur, and central nervous system symptoms (agitation, stupor, seizures, etc.) may arise, so seek appropriate medical treatment immediately. When administering by injection, it should be given slowly via a drip infusion rather than rapid intravenous injection, and care should be taken to prevent pain or inflammation at the injection site. This medication is alkaline, so it is advisable to avoid mixing it with other medications for injection.

Serious side effects

Urticaria, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, anaphylactic shock, anaphylactoid reactions, skin and mucous membrane syndrome (Stevens-Johnson syndrome), toxic epidermal necrolysis (Lyell syndrome), severe skin adverse reactions, jaundice, hepatitis, liver dysfunction, acute renal failure, renal failure, severe edema or urination abnormalities, severe edema with high blood pressure, pneumonia, difficulty breathing, respiratory issues, sudden

Mild side effects

• Photosensitivity reactions
• fixed drug eruptions
• rash
• fever
• blisters
• urticaria-like erythema
• alopecia
• erythema multiforme
• gastritis
• thirst

This medication should be stored in a sealed container to prevent exposure to air and kept in a cool place below 25 degrees. This preserves the effectiveness of the medication and prevents deterioration.

Appearance

It is an injection solution filled with a nearly transparent liquid.

Package unit

1 vial (10 milliliters) × 1, 3, 5, 10, 20, 30, 50, 100